Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers

PURPOSE: Cisplatin resistance is a major concern in ovarian cancer treatment. The aim of this study was to investigate if wedelolactone could perform better in resistant ovarian cancer cells when used in combination with cisplatin. METHODS: Growth inhibitory potential of wedelolactone and cisplatin...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Drug Des Devel Ther
Main Authors: Sarwar, Sadia, Alamro, Abir A, Alghamdi, Amani A, Naeem, Komal, Ullah, Salamat, Arif, Muazzam, Yu, Jun Qing, Huq, Fazlul
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2021
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164677/
https://ncbi.nlm.nih.gov/pubmed/34079223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S288707
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker